Zarnegar-Lumley S, Pommert L, Lacayo NJ, Petit A, Shukla N, Stevens A, Gibson A, Tarlock K. Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome. haematol [Internet]. 2020Sep.10 [cited 2026Sep.16];. Available from: https://haematologica.org/article/view/14392